skip to main content
Informa pharma logo

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Citeline
Search Icon Pharma Report StoreProduct loginProductLogin
Global Search Configuration

Analysis, insight and consultancy

Our analysis, insight and consultancy services span drug, device, company, clinical trial and market intelligence. All our services are delivered by an authoritative team of industry experts in key markets around the globe. And because our approach is interconnected, our analysts can give a broader perspective, identifying disruptive events, and in turn, helping you spot opportunities and mitigate risk.

Our specialities

news and insight analyst page expertise in all areas pharma intelligence

新闻和洞察

我们提供无与伦比、每日更新的全球洞察，源自大量权威数据集，并通过人工验证使其锦上添花。

data and analysis indepth company profiles pharma intelligence

数据和分析

我们的高品质数据覆盖42000家企业、175个国家的248000万次临床试验，以及用于1400种疾病的65000种药物。

consultancies pharma intelligence

咨询

我们的定制临床、商业和市场准入解决方案旨在帮助您做出更明智的决策，带来更好的投资回报。

ask the analyst pharma intelligence

全球行业专家

就职于相互关联的全球网络中，我们的65名记者和300多名分析师可提供全面的分析和报告。

dedicated account manager pharma intelligence

可信赖的合作伙伴

我们是3000多家企业的可信赖合作伙伴，包括50大制药公司和10大合同研究机构。

gold standard service product developments pharma intelligence

黄金标准服务

我们的客户服务团队将全程为您提供支持，以使我们的洞察、情报和定制解决方案满足您的需求。

solution to suity our need epidemiology pharma intelligence

定制解决方案

从单一报告、数据下载到企业订阅、定制咨询，我们能根据您的确切需求提供精确的解决方案。

 Meet the team

Editor

Alexandra Shimmings

Executive Editor, Commercial/R&D

Alexandra Specialises in

  • Biotech
  • Biopharma pipeline strategy
  • CommercialStrategy

28+ years of experience

Full profile
Management

Michael Hay

Head of Intelligence Products
Michael Hay

Michael Specialises in

  • Business Development and Licensing
  • CommercialStrategy

23+ years of experience

Full profile
See more specialists

How we've helped other businesses

"We at GSK believe that it’s critical for the pharmaceutical industry to produce drugs that deliver value for patients, providers and payers. We have found RxScorecard™ to be an insightful framework for assessing and comparing the value of drugs, both marketed and developmental assets. The perspective it provides supports improved customer-focused development and commercialization, and we and our customers can benefit from its use.”

​Jack Bailey ​President GlaxoSmithKline U.S.

See all case studies

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy and Terms & Conditions for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device. Cookie Policy

I AGREE Cookies Settings